Researchers for this paper conducted a cross-sectional survey on the various diagnostic and treatment practices of Dutch neurologists who cared for patients with inflammatory demyelinating polyradiculoneuropathy (CIDP). The study included 44 neurologists who completed the survey. Respondents to the survey indicated that they used the European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) 2010 CIDP guideline for diagnosis in 77% of cases and treatment in 50%. A total of 57% indicated the presence of demyelinating electrophysiological findings was required for a confirmed diagnosis of CIDP. Intravenous immunoglobin (IVIG) was the first choice for the majority of respondents, while indications to start, optimize, or withdraw IVIG varied among respondents. “Our findings suggest that it would be helpful if the EFNS/PNS guideline, which is currently undergoing revision, could be more specific about: (a) the minimal set of electrophysiological requirements to diagnose CIDP, (b) the possible added value of NUS and MRI in the diagnostic workup of CIDP, especially in patients not meeting the electrodiagnostic criteria, (c) the most relevant serological examinations, and (d) a clear treatment advice,” they wrote.

This article was originally published here